Diagnostic performance analysis of Xpert MTB/RIF in lymph node tuberculosis: A retrospective study [0.03%]
结核病菌Xpert MTB/RIF检测诊断淋巴结结核的效能分析：一项回顾性研究
Lingshan Dai,Lijun Peng,Tingting Fang et al.
Lingshan Dai et al.
Aims: To retrospectively analyze the diagnostic efficacy of Xpert MTB/RIF (Xpert) in lymph node tuberculosis (LNTB). Methods: Sensitivi...
Utility of microbial cell free DNA next-generation sequencing for diagnosis and management of infectious diseases [0.03%]
微生物细胞游离DNA的下一代测序在感染性疾病诊疗中的应用价值
Riley Aiden-Croix Thompson,Monica A Donnelley,Kate Trigg et al.
Riley Aiden-Croix Thompson et al.
Microbial cell-free DNA (mcfDNA) sequencing is a promising tool to identify infectious pathogens when traditional methods fail to identify the causative agent. We performed a retrospective observational cohort study to evaluate clinical out...
Performance evaluation of the Access anti-HBc Total assay on the DxI 9000 Access Immunoassay Analyzer [0.03%]
Access抗HBc Total检测在DxI 9000免疫检测分析仪上的性能评估研究
Simplice Dzamitika,Françoise Le Boulaire,Catherine Coignard et al.
Simplice Dzamitika et al.
This study evaluated the diagnostic and analytical performances of the Access anti-HBc Total assay on the DxI 9000 Access Immunoassay System (Beckman Coulter Inc.). The multicenter study involved both prospective and retrospective sample co...
Non-O1/non-O139 Vibrio cholerae bacteremia and hepatitis in diabetic patient, France, winter 2019 [0.03%]
法国2019年冬季糖尿病患者感染非O1/非O139霍乱弧菌并发细菌血症和肝炎
Sebastien Laurens,Nathalie Wilhelm,Frédéric Février et al.
Sebastien Laurens et al.
Objectives: Vibrio cholerae non-O1/non-O139 (NOVC) bacteremia is infrequently reported in Western countries and is associated with unfavorable outcome. Pa...
Dynamic changes in serum (1-3)-β-D-glucan caused by intravenous immunoglobulin infusion: A prospective study [0.03%]
静脉注射免疫球蛋白引起的血清（1,3）-β-D-葡聚糖动态变化：一项前瞻性研究
Xixi Wan,Rong Liufu,Ruiting Liu et al.
Xixi Wan et al.
Purpose: The purpose of this study was to investigate the dynamic changes in serum (1-3)-β-D-glucan (BDG) caused by intravenous immunoglobulins (IVIG) infusion in adults. ...
Advanced integrative molecular platform for high-throughput screening of drug-resistant tuberculosis [0.03%]
高通量筛选耐药结核病药物的先进集成分子平台
Minal Dakhave,Trupti Rale,Harshada Suryawanshi et al.
Minal Dakhave et al.
A real time-polymerase chain reaction-based test in lyophilized form, was developed to simultaneously identify Mycobacterium tuberculosis complex (MTC) by targeting IS6110, rrs as dual markers, as well as mutations causing rifampicin and is...
Tropheryma whipplei detected by metagenomic next-generation sequencing in bronchoalveolar lavage fluid [0.03%]
支气管肺泡灌洗液中通过宏基因组下一代测序检测到的特氏惠普菌
Lan Min Lai,Xin Yu Zhu,Rui Zhao et al.
Lan Min Lai et al.
Whipple's disease is a chronic systemic infectious disease that mainly affects the gastrointestinal tract. In some cases, Tropheryma whipplei can cause infection at the implant site or even throughout the body. In this study, we collected a...
Lemierre's syndrome complicating multiple organ failure caused by Fusobacterium necrophorum subsp. funduliforme F1260: Case report and review [0.03%]
由Fusobacterium necrophorum subsp. funduliforme F1260引起的 Lemierre综合征合并多器官功能衰竭的病例报告及文献复习
Lizhong Zhang,Xiaoyan Li,Ruixue Wang et al.
Lizhong Zhang et al.
We described a case of a 24-year-old man with multiple organ failure caused by Fusobacterium necrophorum subsp. funduliforme F1260. This is the first described case of Lemierre's syndrome with multiple organ failure due to F. necrophorum su...
Impact of a 20 mg/kg vancomycin loading dose on early AUC target attainment [0.03%]
20毫克/千克万古霉素首剂对早期曲线下面积达标率的影响
Samuel Yang,Angela Antoniello,Steven Smoke
Samuel Yang
This retrospective chart review evaluated whether 20 mg/kg vancomycin loading doses increase early area under the curve (AUC) target attainment within 48 hours in comparison to non-loading dose regimens. There were no differences between gr...
Saccharomyces cerevisiae fungemias: how heterogenous is their management? [0.03%]
酿酒酵母菌血流感染：其处理方式有多异质？
Coumba Diop,Julie Descy,Rosalie Sacheli et al.
Coumba Diop et al.
Saccharomyces cerevisiae is a yeast used mainly as a probiotic for prevention or treatment of diarrhoea. However, the prevalence of S. cerevisiae fungemia has risen over the past years, notably among patients with predisposing factors. This...